A short intrinsically disordered domain of MCPyV ALTO regulates host TBK1 signaling and MCPyV latency.

UNLABELLED

Merkel Cell Polyomavirus (MCPyV) is an oncogenic human polyomavirus that latently infects most adults. Although the causative link between MCPyV and Merkel Cell Carcinoma (MCC) is well established, the molecular mechanisms that govern viral latency and prevent oncogenic progression remain poorly understood. We previously reported that the MCPyV early region protein ALTO is a key modulator of the STING-TBK1 signaling axis, enabling the virus to co-opt host innate immune pathways to suppress excessive viral replication and promote latency over transformation. In this study, we expand on this model by identifying a short, essential domain within ALTO that is required for TBK1 activation. This domain, which we term LIT (Lost in Tau), is necessary for ALTO-TBK1 interaction but dispensable for ALTO trafficking and its interactions with STING or Src. When expressed alone, the LIT domain functions as a dominant negative inhibitor of wild-type ALTO, competitively blocking TBK1 activation through a novel TBK1 interaction domain. Deletion of the LIT domain from ALTO not only abolishes TBK1 interaction and downstream phosphorylation but also eliminates TBK1-mediated suppression of MCPyV replication during early infection of human dermal fibroblasts (HDFs). These findings provide mechanistic insight into how ALTO promotes viral persistence and immune evasion. More broadly, they highlight the functional importance of intrinsically disordered regions in modulating host-virus interactions and suggest that MCPyV latency is actively maintained through a finely tuned balance of pro- and anti-viral signaling. Targeting domains such as LIT may offer new strategies for regulating TBK1 activity or disrupting viral persistence.

IMPORTANCE

Merkel cell polyomavirus causes lifelong, latent infections in the skin of most people. When this latency is perturbed, the virus can give rise to Merkel Cell Carcinoma, an aggressive and difficult-to-treat skin cancer. Efforts to prevent this cancer depend on understanding what controls viral latency and persistence. We previously reported that MCPyV stimulates the host's STING-TBK1 signaling axis to limit its own replication. In this work, we identify and characterize a short amino acid motif within the ALTO protein's intrinsically disordered region that is required for this immune-stimulating activity. This region appears to be critical for helping the virus maintain latency by fine-tuning the host's response. Our findings provide new insight into MCPyV's latency mechanism and may help guide future approaches to prevent or treat Merkel cell carcinoma by targeting viral or cellular factors involved in long-term infection.